ZURICH (Reuters) - Swiss drugmaker Novartis sees mid-single-digit sales growth from its core businesses in 2019 as it sheds its Alcon eyecare unit and a U.S. generics pills business to focus on newer high-tech drugs. https://ift.tt/eA8V8J
from Home Page via vilayatimall.com Find Latest Coupons & Offers For Online Shopping Sites.
No comments:
Post a Comment